Molecular Modelling Studies To Suggest Novel Scaffolds Against Sars-Cov Target Enzymes

dc.authorid Sahin, Ahmet Fatih/0000-0001-7802-8730
dc.authorscopusid 57410184700
dc.authorscopusid 55894906300
dc.authorscopusid 8912960500
dc.authorwosid ŞAHİN, Abdullah Fahri/JUU-2457-2023
dc.authorwosid Akdemir, Atilla/G-2595-2015
dc.authorwosid Küçükgüzel, Ş.Güniz/AAQ-8954-2021
dc.contributor.author Şahin, A.F.
dc.contributor.author Küçükgüzel, Şükriye Güniz
dc.contributor.author Küçükgüzel, Ş.G.
dc.contributor.author Akdemir, A.
dc.contributor.other Eczacılık Meslek Bilimleri Bölümü
dc.date.accessioned 2025-01-11T13:01:38Z
dc.date.available 2025-01-11T13:01:38Z
dc.date.issued 2021
dc.department Fenerbahçe University en_US
dc.department-temp Şahin A.F., Department of Drug Discovery and Development, Institute of Health Sciences, Bezmialem Vakif University, Fatih, İstanbul, 34093, Turkey; Küçükgüzel Ş.G., Vocational School of Health Services, Fenerbahçe University, Ataşehir, Istanbul, 34758, Turkey; Akdemir A., Department of Drug Discovery and Development, Institute of Health Sciences, Bezmialem Vakif University, Fatih, İstanbul, 34093, Turkey, Computer-aided Drug Discovery Laboratory, Department of Pharmacology, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, 34093, Turkey en_US
dc.description.abstract In this study, molecular modelling study of previously synthesized compounds against SARS-CoV-2 target enzyme was performed. A subset of 156 compounds from an in-house database has been subjected to molecular modelling studies against the SARS-CoV-2 ADP-ribose phosphatase (ADRP, NSP3), Papain-like protease (PLpro ), and uridine specific endoribonuclease (NSP15) enzymes. We have identified one compound that is expected to inhibit the SARS-CoV-2 ADRP enzyme and one compound that is expected to inhibit the NSP15 enzyme. © 2021 Marmara University Press ISSN: 2630-6344. en_US
dc.description.woscitationindex Emerging Sources Citation Index
dc.identifier.citation 1
dc.identifier.doi 10.29228/jrp.96
dc.identifier.endpage 1017 en_US
dc.identifier.issn 2630-6344
dc.identifier.issue 6 en_US
dc.identifier.scopus 2-s2.0-85122758556
dc.identifier.scopusquality Q4
dc.identifier.startpage 1010 en_US
dc.identifier.trdizinid 488949
dc.identifier.uri https://doi.org/10.29228/jrp.96
dc.identifier.volume 25 en_US
dc.identifier.wos WOS:000725063300028
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Marmara University en_US
dc.relation.ispartof Journal of Research in Pharmacy en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.scopus.citedbyCount 1
dc.subject Adrp en_US
dc.subject Covid-19 en_US
dc.subject Docking en_US
dc.subject Molecular Dynamics en_US
dc.subject Nsp15 en_US
dc.subject PlPro en_US
dc.subject Sars-Cov-2 en_US
dc.title Molecular Modelling Studies To Suggest Novel Scaffolds Against Sars-Cov Target Enzymes en_US
dc.type Article en_US
dc.wos.citedbyCount 1
dspace.entity.type Publication
relation.isAuthorOfPublication ccdbdc32-5572-44d5-8ee3-7caed45f6422
relation.isAuthorOfPublication.latestForDiscovery ccdbdc32-5572-44d5-8ee3-7caed45f6422
relation.isOrgUnitOfPublication 5052e089-e75d-4aec-a280-6353973e4819
relation.isOrgUnitOfPublication.latestForDiscovery 5052e089-e75d-4aec-a280-6353973e4819

Files